These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

949 related items for PubMed ID: 15080257

  • 41. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W, AgRhaly A, Koch I, Koumaré B, Simaga SY, Diallo D.
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [Abstract] [Full Text] [Related]

  • 42. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM, Manor Y, Sofer D, Swartz T, Mendelson E.
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [Abstract] [Full Text] [Related]

  • 43. [A study on immunization of polio vaccine. I. Observation on an improved immunization schedule].
    Su W.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):281-3. PubMed ID: 1664295
    [Abstract] [Full Text] [Related]

  • 44. Results of a program successfully combining live and killed polio vaccines.
    Lasch EE, Abed Y, Gerichter CB, Massri ME, Marcus O, Hensher R, Goldblum N.
    Isr J Med Sci; 1983 Nov; 19(11):1021-3. PubMed ID: 6662685
    [Abstract] [Full Text] [Related]

  • 45. Monovalent type 1 oral poliovirus vaccine in newborns.
    el-Sayed N, el-Gamal Y, Abbassy AA, Seoud I, Salama M, Kandeel A, Hossny E, Shawky A, Hussein HA, Pallansch MA, van der Avoort HG, Burton AH, Sreevatsava M, Malankar P, Wahdan MH, Sutter RW.
    N Engl J Med; 2008 Oct 16; 359(16):1655-65. PubMed ID: 18923170
    [Abstract] [Full Text] [Related]

  • 46. [Levels of specific antibodies against poliomyelitis virus and degree of immune protection in Umbria population].
    Stagni G, Merletti L, De Rosa F.
    Boll Ist Sieroter Milan; 1979 Jul 31; 58(3):210-5. PubMed ID: 229884
    [Abstract] [Full Text] [Related]

  • 47. [Serological and epidemiological effects of Sabin oral vaccination against poliomyelitis in Tyrol].
    Bauer P.
    Arch Hyg Bakteriol; 1968 Dec 31; 152(5):405-9. PubMed ID: 5741512
    [No Abstract] [Full Text] [Related]

  • 48. Childhood mortality after oral polio immunisation campaign in Guinea-Bissau.
    Aaby P, Hedegaard K, Sodemann M, Nhante E, Veirum JE, Jakobsen M, Lisse I, Jensen H, Sandström A.
    Vaccine; 2005 Feb 25; 23(14):1746-51. PubMed ID: 15705481
    [Abstract] [Full Text] [Related]

  • 49. Response to immunization against polio after allogeneic marrow transplantation.
    Ljungman P, Duraj V, Magnius L.
    Bone Marrow Transplant; 1991 Feb 25; 7(2):89-93. PubMed ID: 1646664
    [Abstract] [Full Text] [Related]

  • 50. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F, Buisman AM, Doornbos G, Woldman J, Kimman TG, Conyn-van Spaendonck MA.
    J Infect Dis; 2005 Mar 15; 191(6):990-9. PubMed ID: 15717277
    [Abstract] [Full Text] [Related]

  • 51. Poliomyelitis vaccination of infants: preimmunization status and seroconversion.
    Choudhury DS, Nossik NN, Bindu, Vijayan P, Raghavan NG, Paul SS.
    Bull World Health Organ; 1973 Mar 15; 48(2):195-8. PubMed ID: 4352611
    [Abstract] [Full Text] [Related]

  • 52. Poliovirus antibody in children from a paediatric hospital in Ibadan, Nigeria.
    Williams JO, David-West TS.
    Rev Roum Virol; 1990 Mar 15; 41(2):129-32. PubMed ID: 2176534
    [Abstract] [Full Text] [Related]

  • 53. Update: mass vaccination with oral poliovirus vaccine--Asia and Europe, 1996.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1996 Oct 25; 45(42):911-4. PubMed ID: 8927014
    [Abstract] [Full Text] [Related]

  • 54. The 2001 serological survey in the Czech Republic--measles.
    Mrázová M, Svandová E, Smelhausová M, Sestáková Z, Benes C.
    Cent Eur J Public Health; 2003 Dec 25; 11 Suppl():S36-41. PubMed ID: 15080258
    [Abstract] [Full Text] [Related]

  • 55. Determination of antigenic properties of vaccine derived poliovirus strains.
    Pliaka V, Achilleos C, Kyriakopoulou Z, Tsakogiannis D, Ruether IG, Gartzonica C, Levidiotou-Stefanou S, Markoulatos P.
    Vaccine; 2010 Dec 10; 29(1):26-33. PubMed ID: 20974307
    [Abstract] [Full Text] [Related]

  • 56. Evaluation of a poliomyelitis immunization campaign in Madras city.
    Balraj V, John TJ.
    Bull World Health Organ; 1986 Dec 10; 64(6):861-5. PubMed ID: 3493855
    [Abstract] [Full Text] [Related]

  • 57. Poliomyelitis immunity status in Italian and foreign subjects.
    Tanzi ML, Bracchi U, Affanni P, Dall'Argine A, Bombarda G, Bellelli E.
    Ann Ig; 1992 Dec 10; 4(4):191-7. PubMed ID: 1284576
    [No Abstract] [Full Text] [Related]

  • 58. The 2001 serological survey in the Czech Republic--rubella.
    Mrázová M, Smelhausová M, Sestáková Z, Svandová E, Benes C.
    Cent Eur J Public Health; 2003 Dec 10; 11 Suppl():S42-9. PubMed ID: 15080259
    [Abstract] [Full Text] [Related]

  • 59. [Implementing secondary poliomyelitis vaccination].
    Pietsch R, Riegel H.
    Gesundheitswesen; 1992 Dec 10; 54(12):714-5. PubMed ID: 1366256
    [Abstract] [Full Text] [Related]

  • 60. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M, Hovi L, Siimes MA, Roivainen M, Hovi T.
    Pediatr Infect Dis J; 1987 Dec 10; 6(12):1106-10. PubMed ID: 2829105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.